How is Emtricitabine and Tenofovir Oral Route dosed?
The oral dosage form of Emtricitabine and Tenofovir is dosed differently based on the patient's weight, age, and medical condition. For treatment of HIV infection, adults and children weighing 35 kilograms (kg) or more should take one tablet once a day, containing 200 mg of Emtricitabine and 300 mg of Tenofovir. Children weighing 17 kg to less than 35 kg who can swallow a whole tablet should follow a dose determined by their doctor. For prevention of HIV infection (Pre-exposure prophylaxis), the dose for adults and children weighing 35 kg or more is one tablet once a day, containing 200 mg of Emtricitabine and 300 mg of Tenofovir. Children weighing less than 35 kg should follow a dose determined by their doctor. It is essential to follow your doctor's orders or the directions on the label and not change the dose unless instructed by your doctor.
What is the dosage form of Emtricitabine and Tenofovir Oral Route?
The oral route dosage forms of Emtricitabine and Tenofovir are tablets.
How is Emtricitabine and Tenofovir Oral Route administered?
Emtricitabine and Tenofovir Oral Route is administered by taking tablets. The dosage for adults and children weighing 35 kg or more, for the treatment of HIV infection, is one tablet once a day, containing 200 mg of Emtricitabine and 300 mg of Tenofovir. For children weighing 17 kg to less than 35 kg, the dose is determined by their body weight and must be prescribed by a doctor. For the prevention of HIV infection (Pre-exposure prophylaxis), the recommended dosage for adults and children weighing 35 kg or more is one tablet once a day, containing 200 mg of Emtricitabine and 300 mg of Tenofovir. Children weighing less than 35 kg will need to have their dose determined by their doctor. It is important to follow the dosage instructions provided by your doctor and to never change the dose unless specifically advised by them.
What are common precautions when taking Emtricitabine and Tenofovir Oral Route?
Common precautions when taking Emtricitabine and Tenofovir Oral Route include:
- Age considerations: Use caution in pediatric patients weighing less than 35 kg for the treatment of HIV infection and in those weighing less than 17 kg for prevention of HIV infection. The safety and efficacy have not been established for these age groups. Elderly patients may require dose adjustments due to age-related liver or kidney problems.
- Breastfeeding: There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Consult your doctor before taking the medication while breastfeeding, and weigh the potential benefits against the potential risks.
- Drug interactions: Inform your doctor of all prescription and nonprescription medications you are using, as this medicine may interact with other drugs, resulting in unwanted side effects or reduced effectiveness.
- Dose adjustments: Follow your doctor's orders or the directions on the label. The dose of this medicine will be different for different patients. Dose adjustments may be necessary for patients with liver or kidney problems.
- Side effects: Be aware of common side effects such as depression, diarrhea, nausea, anxiety, back pain, belching, difficulty in moving, heartburn, joint pain or swelling, lack or loss of strength, pain, passing of gas, stomach upset, sweating, trouble sleeping, vomiting, and weight loss. Contact your healthcare professional if these or other side effects occur. Remember to consult your doctor or pharmacist for specific precautions related to your medical history and personal circumstances.